NCT02957682 Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo Status COMPLETED Phase PHASE4
NCT02954692 A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey Status COMPLETED Phase PHASE4
NCT02948959 Evaluation of Dupilumab in Children With Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT02941367 Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan Status COMPLETED Phase PHASE4
NCT02940379 A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol Status COMPLETED Phase PHASE1
NCT02926950 Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin Status COMPLETED Phase PHASE3
NCT02926937 Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy Status COMPLETED Phase PHASE3
NCT02921971 Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT02914886 Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) Status COMPLETED Phase PHASE4
NCT02912468 A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps Status COMPLETED Phase PHASE3
NCT02910518 A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02903160 Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) Status COMPLETED Phase PHASE2
NCT02898454 Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Status COMPLETED Phase PHASE3
NCT02890992 An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT02890147 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control Status COMPLETED Phase N/A
NCT02890134 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort Status COMPLETED Phase N/A
NCT02890121 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Status COMPLETED Phase N/A
NCT02882178 Consensus Method to Evaluate the Conformity of Prescription of a Chemotherapy Status COMPLETED Phase N/A
NCT02878603 Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) Status COMPLETED Phase PHASE3